What is Obiter Research?
Obiter Research operates as a specialized chemistry research contract organization, focusing on the rediscovery and manufacturing of critical materials that have been lost or disrupted in modern supply chains. The company provides a comprehensive suite of services, including laboratory-scale chemistry, advanced manufacturing, and rigorous analytical method development. By prioritizing quality control and collaborative innovation, Obiter Research serves as a technical backbone for clients facing complex chemical challenges. Their business model is built on the premise of supply chain resilience, ensuring that essential chemical components remain available for industrial and research applications despite global market volatility.
How much funding has Obiter Research raised?
Obiter Research has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Obiter Research
PPP
Public-Private Partnership
What's next for Obiter Research?
With this late-stage capital, Obiter Research is expected to scale its manufacturing operations and deepen its investment in analytical quality control infrastructure. The strategic focus will likely shift toward optimizing production efficiency and expanding the firm's capacity to handle larger, more complex chemical synthesis projects. As the company matures, it will likely leverage this financial backing to enhance its competitive advantage in the contract research organization sector, potentially exploring new partnerships to further stabilize the supply of critical materials. The firm's trajectory suggests a transition toward becoming a dominant player in the industrial chemistry landscape, driven by a commitment to solving systemic supply chain vulnerabilities.
See full Obiter Research company page
